NASDAQ$PETS
PetMed Express · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
PetMed Express reported a decrease in sales and net income for Q4 2021, while full-year results showed growth in both areas.
PetMed Express reported a decrease in sales for the fourth quarter, with a slight decrease in net income. However, the company experienced overall growth in sales and net income for the full fiscal year. The decrease in sales for the quarter was attributed to colder weather and demand being pulled forward due to the pandemic.
- Q4 sales decreased by 3.5% to $71.7 million compared to the same period last year.
- Q4 net income decreased by 2.7% to $6.8 million, or $0.34 diluted per share.
- Average order value increased to approximately $93, compared to $90 for the same quarter the prior year.
- The company acquired approximately 88,000 new customers in Q4, compared to 107,000 in the same period last year.
Headline financials
Revenue & EPS history
PetMed Express · Revenue · Quarterly
$71.7M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2021
-0.0%
Avg return
Earnings day
-1.6%
Avg return
5 days after
-0.4%
Avg return
30 days after
42%
27 / 65 earnings
Positive
+40.8%
Q2 2020
Best reaction
-26.4%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -16.4% | -21.1% | — | |
| Q3 2026 | -3.6% | -8.7% | -15.5% | |
| Q4 2025 | +0.0% | -4.9% | -6.6% | |
| Q2 2026 | -1.4% | -2.7% | -8.2% | |
| Q1 2026 | -1.1% | -1.4% | -6.9% | |
| Q3 2025 | -14.8% | -20.1% | -22.7% | |
| Q2 2025 | +34.5% | +27.2% | +35.0% | |
| Q1 2025 | -11.0% | -13.0% | -4.5% | |
| Q4 2024 | -0.7% | -1.7% | -7.4% | |
| Q3 2024 | +0.2% | -1.2% | +8.9% | |
| Q2 2024 | -26.4% | -23.0% | -22.6% | |
| Q1 2024 | -2.8% | -6.4% | -20.0% | |
| Q4 2023 | +6.7% | +1.0% | -6.6% | |
| Q3 2023 | -11.1% | -13.3% | -19.6% | |
| Q2 2023 | -10.5% | -4.7% | -15.5% | |
| Q1 2023 | +4.3% | +4.2% | +0.9% | |
| Q4 2022 | +6.9% | +2.0% | +3.0% | |
| Q3 2022 | +7.2% | +7.7% | +3.4% | |
| Q2 2022 | +5.1% | +5.1% | +5.2% | |
| Q1 2022 | +7.1% | +13.0% | +3.2% | |
| Q4 2021 | +2.8% | +0.5% | +56.5% | |
| Q3 2021 | -14.3% | -11.1% | +3.2% | |
| Q2 2021 | -2.2% | -3.5% | -1.9% | |
| Q1 2021 | -16.0% | -23.8% | -17.4% | |
| Q4 2020 | +3.6% | -4.0% | -7.5% | |
| Q3 2020 | -11.0% | -11.2% | +4.0% | |
| Q2 2020 | +40.8% | +32.8% | +21.7% | |
| Q1 2020 | +2.5% | -1.5% | +5.1% | |
| Q4 2019 | -9.0% | -9.7% | -18.9% | |
| Q3 2019 | -6.2% | -3.4% | -3.1% | |
| Q2 2019 | +2.6% | +1.1% | -9.7% | |
| Q1 2019 | -13.0% | -11.8% | -6.4% | |
| Q4 2018 | -0.9% | +1.4% | +15.1% | |
| Q3 2018 | -4.8% | -10.2% | -12.0% | |
| Q2 2018 | +4.4% | -5.0% | +9.0% | |
| Q1 2018 | +18.6% | +19.3% | -10.7% | |
| Q4 2017 | +34.7% | +41.2% | +48.4% | |
| Q3 2017 | -5.1% | -5.4% | -3.6% | |
| Q2 2017 | -3.2% | -4.0% | +6.6% | |
| Q1 2017 | +6.0% | +5.8% | +3.3% | |
| Q4 2016 | +2.9% | — | — | |
| Q3 2016 | -4.8% | — | — | |
| Q2 2016 | +2.1% | — | — | |
| Q1 2016 | +0.5% | — | — | |
| Q4 2015 | +2.6% | — | — | |
| Q3 2015 | +14.3% | — | — | |
| Q2 2015 | -3.7% | — | — | |
| Q1 2015 | +5.0% | — | — | |
| Q4 2014 | +1.6% | — | — | |
| Q3 2014 | -12.0% | — | — | |
| Q2 2014 | -10.3% | — | — | |
| Q1 2014 | +12.7% | — | — | |
| Q4 2013 | -0.5% | — | — | |
| Q3 2013 | +7.0% | — | — | |
| Q2 2013 | +6.9% | — | — | |
| Q1 2013 | -16.3% | — | — | |
| Q4 2012 | -5.4% | — | — | |
| Q4 2010 | -5.4% | — | — | |
| Q3 2011 | -0.2% | — | — | |
| Q3 2012 | -0.2% | — | — | |
| Q2 2012 | -0.8% | — | — | |
| Q2 2011 | -0.8% | — | — | |
| Q1 2012 | -0.1% | — | — | |
| Q1 2011 | -0.1% | — | — | |
| Q4 2011 | -0.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro